Low-molecular-weight heparins, acenocoumarol and bone density.
Wawrzyńska
L
L
Department of Internal Chest Medicine, Institute of Tuberculosis and Lung Diseases, Medical University, Warsaw, Poland. I.wawrzynska@igichp.edu.pl
Przedlacki
J
J
Hajduk
B
B
Bielska Falda
H
H
Tomkowski
W
W
Torbicki
A
A
D000074:Acenocoumarol / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced; D012189:Retrospective Studies
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D000074:Acenocoumarol